Adverum Biotechnologies (ADVM)

Adverum Biotechnologies (ADVM) Stock Price & Analysis


ADVM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.53 - $1.82
Previous Close$0.8
Average Volume (3M)437.64K
Market Cap
Enterprise Value-$16.87M
Total Cash (Recent Filing)$203.26M
Total Debt (Recent Filing)$105.70M
Price to Earnings (P/E)-0.5
May 10, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.58
Shares Outstanding99,729,025
10 Day Avg. Volume814,751
30 Day Avg. Volume437,636
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.36
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)242.90
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.11
Price Target Upside150.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adverum Biotechnologies’s price range in the past 12 months?
Adverum Biotechnologies lowest stock price was $0.53 and its highest was $1.82 in the past 12 months.
    What is Adverum Biotechnologies’s market cap?
    Currently, no data Available
    When is Adverum Biotechnologies’s upcoming earnings report date?
    Adverum Biotechnologies’s upcoming earnings report date is May 10, 2023 which is in 42 days.
      How were Adverum Biotechnologies’s earnings last quarter?
      Currently, no data Available
      Is Adverum Biotechnologies overvalued?
      According to Wall Street analysts Adverum Biotechnologies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Adverum Biotechnologies pay dividends?
        Adverum Biotechnologies does not currently pay dividends.
        What is Adverum Biotechnologies’s EPS estimate?
        Adverum Biotechnologies’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Adverum Biotechnologies have?
        Adverum Biotechnologies has 99,729,030 shares outstanding.
          What happened to Adverum Biotechnologies’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Adverum Biotechnologies?
          Among the largest hedge funds holding Adverum Biotechnologies’s share is Versant Venture Management, LLC. It holds Adverum Biotechnologies’s shares valued at 3M.


            Adverum Biotechnologies Stock Smart Score

            The Adverum Biotechnologies stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Adverum Biotechnologies

            Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr. and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.


            Top 5 ETFs holding ADVM

            Market Value
            Smart Score
            iShares Core S&P Total U.S. Stock Market ETF
            Dimensional US Core Equity Market ETF
            Up to five ETFs with an Outperform Smart Score that hold ADVM. The ETFs are listed according to market value of ADVM within the ETF


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Armata Pharmaceuticals
            Eliem Therapeutics
            Fortress Biotech
            Xilio Therapeutics

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis